Group News - BYHEALTH

Group News

 Home > About Us > Group News

We always have something new



Leading with strategic initiative— 2025 Letter to Shareholders from the Chairman of BYHEALTH

Leading with strategic initiative in 2025 must also focus on eliminating unnecessary work and cutting budgets that do not contribute to product value, user value, or operational value. As a company still in its growth phase, we must avoid turning "operations" into "management," which can lead to premature stagnation and the risks of organizational complacency.

BYHEALTH and Chinese Scientists Collaborate on a Groundbreaking Metabolic Health Evaluation System

BYHEALTH, in collaboration with the Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, and the Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences achieved a pioneering breakthrough in their research on a “Homeostasis-Based Health Evaluation System.”

Nature spotlights BYHEALTH R&D innovations on scientific nutrition，including PCC1 and patented probiotics

On June 15, Nature the authoritative scientific journal published a supplement on nutrition researches in China for the first time, and released an interview article EXPLORING NEW FRONTIERS IN HEALTH MANAGEMENT THROUGH NUTRITION RESEARCH, highlighted several cutting-edge research results of BYHEALTH R&D innovations on scientific nutrition, including PCC1 and patented probiotics.

The World’s First Large-scale Study of Association of NAD+ Contents with Aging

The research is jointly directed by Shanghai General Hospital Affiliated to School of Medicine, Shanghai Jiao Tong University (SJTU), Jinan University and BYHEALTH Nutrition and Health Research Institute, in collaboration with many other famous national and international institutions of higher education and scientific research institutes.

Two National Invention Patents Conferred on BYHEALTH’s Self-developed Indigenous Strain

China's local probiotics family welcomes another new member. With 7 years of strenuous effort, Lactobacillus Paracasei LPB27, a fine intestinal strain originated from healthy Chinese infants, sees the light of day.



News

Nature Metabolism announced the discovery of a blockbuster anti-aging substance: PCC1

Nature Metabolism announced the discovery of a blockbuster anti-aging substance: PCC1

On December 7, the world’s top scientific journal Nature Metabolism released a major research paper, "The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice".

2021 Letter to the Shareholders from the Chairman of Byhealth

2021 Letter to the Shareholders from the Chairman of Byhealth

In 2021, the past pandemic shall be over, let’s embark on the journey in the dawn. Wish the nation and people peace and prosperity.

BYHEALTH partners with UNICEF through the First 1,000 Days Early Childhood Nutrition Plan

BYHEALTH partners with UNICEF through the First 1,000 Days Early Childhood Nutrition Plan

On October 26, BYHEALTH and UNICEF launched a partnership in Zhuhai to improve nutrition in the first 1,000 Days of life. BYHEALTH will donate more than RMB 10 million to support UNICEF in strengthening infant and young child feeding practices as well as the policy and social environment in China from 2020 to 2022.

Introducing Dried Blood Spot Analysis, BYHEALTH Ascends to a New Height on Precision Nutrition

Introducing Dried Blood Spot Analysis, BYHEALTH Ascends to a New Height on Precision Nutrition

The“Precision Nutrition China Summit 2020” was convened in Shanghai from November 16 to 17. Experts in nutrition, medical and health industry were summoned together to make beneficial explorations on pooling wisdom, consolidating resources, and innovating for better leveraging the core role of nutrition science in promoting health awareness, and preventing and treating diseases in the post-epidemic era.

A new continent can never be discovered with an old map

A new continent can never be discovered with an old map

A new continent can never be discovered with an old map. When the industry changes discontinuously, there would be a great cognitive challenge. Such cognitive challenge determines where we should go and how we look at the ultimate industry objectives. We should make new judgements based on the old map and explore new growth opportunities with new cognitions. We would not have the future by clinging to what we know before.

BY-HEALTH Donates 10 Million Yuan to the Novel Coronavirus Pneumonia Battlefront

BY-HEALTH Donates 10 Million Yuan to the Novel Coronavirus Pneumonia Battlefront

The highly contagious coronavirus has become the shared concern of billions of Chinese. On January 27th, BY-HEALTH Co., Ltd. donated 10 million yuan to China Charity Federation and established a “special funds for novel coronavirus pneumonia”.

<
1
2
3
4
>